Aethlon Medical Statistics
Total Valuation
Aethlon Medical has a market cap or net worth of $2.53 million. The enterprise value is -$2.14 million.
Important Dates
The next confirmed earnings date is Wednesday, August 13, 2025, after market close.
Earnings Date | Aug 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Aethlon Medical has 2.01 million shares outstanding. The number of shares has increased by 396.93% in one year.
Current Share Class | 2.01M |
Shares Outstanding | 2.01M |
Shares Change (YoY) | +396.93% |
Shares Change (QoQ) | +4.15% |
Owned by Insiders (%) | 1.39% |
Owned by Institutions (%) | 4.02% |
Float | 1.65M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.49 |
P/TBV Ratio | 0.49 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.16.
Current Ratio | 3.13 |
Quick Ratio | 2.90 |
Debt / Equity | 0.16 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -924.06 |
Financial Efficiency
Return on equity (ROE) is -245.88% and return on invested capital (ROIC) is -92.25%.
Return on Equity (ROE) | -245.88% |
Return on Assets (ROA) | -74.82% |
Return on Invested Capital (ROIC) | -92.25% |
Return on Capital Employed (ROCE) | -171.08% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.49M |
Employee Count | 9 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.50% in the last 52 weeks. The beta is 1.72, so Aethlon Medical's price volatility has been higher than the market average.
Beta (5Y) | 1.72 |
52-Week Price Change | -47.50% |
50-Day Moving Average | 1.55 |
200-Day Moving Average | 3.24 |
Relative Strength Index (RSI) | 45.08 |
Average Volume (20 Days) | 128,098 |
Short Selling Information
The latest short interest is 85,343, so 4.24% of the outstanding shares have been sold short.
Short Interest | 85,343 |
Short Previous Month | 229,563 |
Short % of Shares Out | 4.24% |
Short % of Float | 5.18% |
Short Ratio (days to cover) | 0.20 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -9.34M |
Pretax Income | -12.21M |
Net Income | -13.39M |
EBITDA | -9.00M |
EBIT | -9.34M |
Earnings Per Share (EPS) | -$8.58 |
Full Income Statement Balance Sheet
The company has $5.50 million in cash and $827,957 in debt, giving a net cash position of $4.67 million or $2.32 per share.
Cash & Cash Equivalents | 5.50M |
Total Debt | 827,957 |
Net Cash | 4.67M |
Net Cash Per Share | $2.32 |
Equity (Book Value) | 5.12M |
Book Value Per Share | 2.55 |
Working Capital | 4.05M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -7.65M |
Capital Expenditures | n/a |
Free Cash Flow | -7.65M |
FCF Per Share | -$3.80 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Aethlon Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -396.93% |
Shareholder Yield | -396.93% |
Earnings Yield | -528.44% |
FCF Yield | -301.78% |
Analyst Forecast
The average price target for Aethlon Medical is $28.75, which is 2,181.75% higher than the current price. The consensus rating is "Buy".
Price Target | $28.75 |
Price Target Difference | 2,181.75% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 1:8.
Last Split Date | Jun 9, 2025 |
Split Type | Reverse |
Split Ratio | 1:8 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |